News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
251,894 Results
Type
Article (11850)
Company Profile (69)
Press Release (239975)
Section
Business (74390)
Career Advice (428)
Deals (14026)
Drug Delivery (34)
Drug Development (36642)
Employer Resources (31)
FDA (7101)
Job Trends (5376)
News (133051)
Policy (12050)
Tag
Academia (821)
Alliances (18732)
Alzheimer's disease (467)
Approvals (7124)
Artificial intelligence (47)
Bankruptcy (73)
Best Places to Work (4385)
Biotechnology (47)
Breast cancer (91)
Cancer (703)
Cardiovascular disease (50)
Career advice (341)
Cell therapy (117)
Clinical research (30136)
Collaboration (213)
Compensation (252)
COVID-19 (889)
C-suite (48)
Data (758)
Diabetes (89)
Diagnostics (2094)
Earnings (30861)
Events (35584)
Executive appointments (161)
FDA (7392)
Funding (193)
Gene therapy (73)
GLP-1 (288)
Government (1432)
Healthcare (6668)
Infectious disease (930)
Inflammatory bowel disease (48)
Interviews (65)
IPO (7740)
Job creations (1233)
Job search strategy (311)
Layoffs (197)
Legal (2342)
Lung cancer (130)
Lymphoma (75)
Manufacturing (104)
Medical device (4054)
Medtech (4054)
Mergers & acquisitions (6432)
Metabolic disorders (194)
Neuroscience (592)
NextGen Class of 2024 (1960)
Non-profit (1797)
Northern California (791)
Obesity (93)
Opinion (88)
Patents (44)
People (20487)
Phase I (8572)
Phase II (12929)
Phase III (10845)
Pipeline (329)
Postmarket research (1514)
Preclinical (3573)
Radiopharmaceuticals (113)
Rare diseases (103)
Real estate (2295)
Regulatory (8840)
Research institute (821)
Resumes & cover letters (62)
Southern California (612)
Startups (1297)
United States (6565)
Vaccines (190)
Weight loss (50)
Date
Last 7 days (111)
Last 30 days (953)
Last 365 days (15192)
2024 (15160)
2023 (16753)
2022 (22014)
2021 (22709)
2020 (20192)
2019 (16787)
2018 (12561)
2017 (11937)
2016 (10555)
2015 (12166)
2014 (8906)
2013 (7200)
2012 (8149)
2011 (9414)
2010 (9175)
Location
Africa (201)
Asia (16732)
Australia (2254)
California (1619)
Canada (613)
China (191)
Colorado (54)
Connecticut (82)
Delaware (51)
Europe (38871)
Florida (206)
Georgia (57)
Illinois (137)
Indiana (107)
Japan (55)
Maryland (232)
Massachusetts (1286)
Michigan (53)
Minnesota (69)
New Jersey (521)
New York (437)
North Carolina (748)
Northern California (791)
Ohio (69)
Pennsylvania (342)
South America (397)
Southern California (612)
Texas (214)
Utah (47)
Washington State (140)
251,894 Results for "c r bard".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IND for ATA-200, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5), cleared to proceed by FDA
November 12, 2024
·
3 min read
Press Releases
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
December 18, 2024
·
8 min read
Atamyo Therapeutics Obtains Regulatory Authorization in Europe to Initiate a Clinical Trial for ATA-200, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2C/R5
Atamyo Therapeutics announced the first authorization of a Clinical Trial Application in Europe for ATA-200, its gene therapy for the treatment of the γ-sarcoglycan related limb-girdle muscular dystrophy Type 2C/R5.
March 26, 2024
·
4 min read
InflaRx Hosts R&D Event Highlighting the Promise of INF904
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today hosted a virtual R&D event focused on the company’s oral small molecule C5aR inhibitor, INF904.
June 5, 2024
·
10 min read
Layoffs
Turnstone Biologics to Lay Off 60% of Workforce, Overhaul C-Suite
Turnstone is shifting resources to focus on clinical advancement of its selected tumor-infiltrating lymphocyte therapy as three C-suite members exit their roles.
October 11, 2024
·
2 min read
·
Angela Gabriel
FDA
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY® (epcoritamab-bysp) for the treatment of adults with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy.
June 26, 2024
·
17 min read
Sponsored
Sino Biological’s New Center for Bioprocessing (C4B): US-Based CRO Services
In October 2023,
Sino Biological, Inc.
opened its
Center for Bioprocessing (C4B)
in Houston, Texas. The C4B represents a considerable global expansion of the company’s contract research service capabilities.
September 9, 2024
·
3 min read
Press Releases
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
December 9, 2024
·
6 min read
Drug Development
Facing ‘Daunting’ Launch Schedule, Moderna to Slash $4B in R&D Spend by 2028
Analysts expressed skepticism about plans detailed by Moderna’s R&D chief Stephen Hoge to trim research spending in preparation for the launch of up to 10 new products.
September 13, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
Founder of Hua Medicine Dr. Li CHEN was awarded the “C.C. Tan Life Science Industrialization Award”
October 24, 2024
·
4 min read
1 of 25,190
Next
